Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Hea Clinic PA

Neither a doctor nor a teaching hospital

Research payments

$1,511,902

1,535 payments

Through program year 2025, Hea Clinic PA is reported as receiving $1,511,902 in research payments, across 1,535 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $78,225 26
2024 Research $193,510 159
2023 Research $332,874 170
2022 Research $213,839 400
2021 Research $513,339 686
2020 Research $104,022 52
2019 Research $76,093 42

Breakdown

Who paid Research payments · program years 2019–2025
  1. Alcon Research LLC $1,189,512 1,481 payments
  2. Apellis Pharmaceuticals, Inc. $103,043 17 payments
  3. Novartis Pharmaceuticals Corporation $100,965 3 payments
  4. Allergan Inc. $48,802 12 payments
  5. Dompe US, Inc. $31,976 4 payments
  6. Sun Pharmaceutical Industries Inc. $16,716 12 payments
  7. EyePoint Pharmaceuticals US, Inc. $7,800 2 payments
  8. Genentech, Inc. $6,400 2 payments
  9. Janssen Research & Development, LLC $6,000 1 payment
  10. Bausch Health US, LLC $687 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Post Approval Study of the AcrySof IQ ReSTOR Toric IOL $461,459 1,054 payments
  2. Clareon Toric vs Eyhance Toric $315,158 165 payments
  3. Contralateral Study of Clareon PanOptix Pro vs. Clareon PanOptix $182,242 175 payments
  4. Exploratory Clinical Study for Techniques Associated with the Fluid Accommodating IOL $155,603 18 payments
  5. An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to MacUlar Edema Secondary to Branch Retinal Vein Occlusi $55,381 2 payments
  6. An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD $51,403 8 payments
  7. An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to MacUlar Edema Secondary to Branch Retinal Vein Occlusion (Raptor) $45,584 1 payment
  8. A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye $31,976 4 payments
  9. A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration $29,608 4 payments
  10. 12 months follow-up observational extension of ILQ137-C002 study (Clareon PanOptix vs Clareon PanOptix IOLs) $26,005 1 payment
What the money was spent on Research payments · program years 2019–2025
  1. Other $16,716 12 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record